Aura Biosciences
AURA
AURA
59 hedge funds and large institutions have $334M invested in Aura Biosciences in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 32 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
4% more funds holding
Funds holding: 57 → 59 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more call options, than puts
Call options by funds: $12K | Put options by funds: $12K
Holders
59
Holding in Top 10
2
Calls
$12K
Puts
$12K
Top Buyers
| 1 | +$9.12M | |
| 2 | +$6.68M | |
| 3 | +$5.21M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$5.06M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.29M |
Top Sellers
| 1 | -$4.54M | |
| 2 | -$557K | |
| 3 | -$514K | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$495K |
| 5 |
Millennium Management
New York
|
-$290K |